4SC AG | Key People and Executives
Clemens M. Doppler
Chairman-Supervisory Board
Helga Rübsamen-Schaeff
Member-Supervisory Board
Joerg von Petrikowsky
Deputy Chairman-Supervisory Board
Manfred Rüdiger
Member-Supervisory Board
Irina Antonijevic
Member-Supervisory Board
Helmut Jeggle
Member-Supervisory Board
Clemens M. Doppler
Chairman-Supervisory Board
Jason Loveridge
Chief Executive Officer
Susanne Danhauser-Riedl
Chief Medical Officer
Frank Hermann
Chief Development Officer
Helga Rübsamen-Schaeff
Member-Supervisory Board
Joerg von Petrikowsky
Deputy Chairman-Supervisory Board
Manfred Rüdiger
Member-Supervisory Board
Irina Antonijevic
Member-Supervisory Board
Helmut Jeggle
Member-Supervisory Board
Anna Niedl
Corporate Communications & IR Contact
Address |
Fraunhoferstrasse 22 Planegg-Martinsried Bayern (Bavaria) 82152 Germany
|
Employees
|
- |
Website |
http://www.4sc.de |
Updated |
07/08/2019 |
4SC AG engages in the development of small molecule drugs that targets cancer through epigenetic mechanisms. It also involves in the preclinical and clinical development of its products. Its assets are resminostat, 4SC-202, and 4SC-208. |